Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.

TitleIdentification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.
Publication TypeJournal Article
Year of Publication2010
AuthorsPoliseno L, Salmena L, Riccardi L, Fornari A, Song MSup, Hobbs RM, Sportoletti P, Varmeh S, Egia A, Fedele G, Rameh L, Loda M, Pandolfi PPaolo
JournalSci Signal
Volume3
Issue117
Paginationra29
Date Published2010 Apr 13
ISSN1937-9145
KeywordsAnimals, Cell Cycle Proteins, Cell Transformation, Neoplastic, DNA-Binding Proteins, Humans, Introns, Male, Mice, Mice, Transgenic, MicroRNAs, Minichromosome Maintenance Complex Component 7, Multigene Family, Nuclear Proteins, Prostatic Neoplasms, Proto-Oncogenes, PTEN Phosphohydrolase
Abstract

PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a tumor suppressor that antagonizes signaling through the phosphatidylinositol 3-kinase-Akt pathway. We have demonstrated that subtle decreases in PTEN abundance can have critical consequences for tumorigenesis. Here, we used a computational approach to identify miR-22, miR-25, and miR-302 as three PTEN-targeting microRNA (miRNA) families found within nine genomic loci. We showed that miR-22 and the miR-106b~25 cluster are aberrantly overexpressed in human prostate cancer, correlate with abundance of the miRNA processing enzyme DICER, and potentiate cellular transformation both in vitro and in vivo. We demonstrated that the intronic miR-106b~25 cluster cooperates with its host gene MCM7 in cellular transformation both in vitro and in vivo, so that the concomitant overexpression of MCM7 and the miRNA cluster triggers prostatic intraepithelial neoplasia in transgenic mice. Therefore, the MCM7 gene locus delivers two simultaneous oncogenic insults when amplified or overexpressed in human cancer. Thus, we have uncovered a proto-oncogenic miRNA-dependent network for PTEN regulation and defined the MCM7 locus as a critical factor in initiating prostate tumorigenesis.

DOI10.1126/scisignal.2000594
Alternate JournalSci Signal
PubMed ID20388916
Grant List / CAPMC / CIHR / Canada
R01 CA-82328-0 / CA / NCI NIH HHS / United States
Related Faculty: 
Massimo Loda, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700